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Abstract Neutrophils undergo periodic cytoskeletal rearrange- 
ments that lead to cycles of shape change, ultimately resulting in 
cell translocation. Repeated stimulation of resting neutrophils 
with subsaturating chemoattractant doses induced transient sinu- 
soidal oscillations in neutrophil filamentous actin content at the 
second and subsequent stimulations. Oscillation frequencies in- 
creased with increasing concentration of the first stimulus. In 
contrast, neutrophils pretreated with the phosphatidylinositol 
3-kinase inhibitor (17-hydroxy)wortmannin displayed shape os- 
cillations with the first stimulation, and the frequencies were 
independent of agonist type and dose. We demonstrate that oscil- 
lations in filamentous actin, which may be critical for neutrophil 
motility, can be induced in untreated cells by natural peptide 
chemoattractants. 
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ment with (17-hydroxy)wortmannin (HWTL an inhibitor of 
phosphatidylinositol-3-kinase [7,9,11]. 'Spontaneous' oscilla- 
tions in 90 ° light scattering and F-actin content have been 
reported in untreated cells upon stimulation with single pulses 
of lipid agonists (leukotriene B4, platelet-activating factor) but 
not with N-formylated peptides [8]. Flow cytometric analysis 
showed that all cells in the population were synchronously 
responding in this cyclic manner [8]. 
Here we show that shape-derived scattering oscillations can 
be reproducibly obtained by repetitive stimulation of cell pop- 
ulations with non-desensitizing doses of the chemoattractants 
N-formyl-Met-Leu-Phe (fMLP), interleukin-8 (IL-8) and com- 
plement fragment 5a (C5a). The oscillation frequency increases 
with increasing preactivating agent concentration and tempera- 
ture but is independent of total F-actin content. We suspect hat 
the cytoskeletal-related shape oscillations induced in suspen- 
sion by peptide chemoattractants represent a fundamental neu- 
trophil response critical for motile behavior. 
1. Introduction 
Motile cells, such as neutrophil leukocytes, change their 
shape and 'crawl' in response to external stimuli by extruding 
and remodeling lamellipods, a process requiring rearrangement 
of cytoskeletal actin. Cycles of small scale shape changes then 
result in net cell translocation [1]. Neutrophil chemoattractants 
induce a rapid transient increase in filamentous actin (F-actin) 
[2-4], and a corresponding transient decrease in light scattering 
[5-7]. In synchronized populations of suspended cells, the opti- 
cal and F-actin transients display parallel, oppositely directed 
sinusoidal oscillations having the same period (8 10 s) [8,9]. 
Scattering theory suggests that the optical oscillations result 
from cyclic alterations in cell body size arising from the isovo- 
lumetric extension and retraction of comparatively weakly scat- 
tering, veil-like lamellipods ('shape changes') [9,10]. Recurring 
lamellipod protrusion and retraction, driven by corresponding 
actin polymerization/depolymerization cycles [9], may be an 
integral feature of the mechanism responsible for the 
amoeboid-like crawling motions typical of cells seeking bacte- 
rial targets. 
Clearly oscillating responses are rarely observed in neutro- 
phil suspensions, but they can be routinely enabled by pretreat- 
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Abbrevations: C5a, complement fragment (anaphylatoxin) 5a; F-actin, 
filamentous actin; fMLP, N-formyl-Met-Leu-Phe; HWT, 17-hydroxy- 
wortmannin; IL-8, interleukin-8. 
2. Experimental 
2.1. Materials" 
HWT and wortmannin were kindly provided by Dr. T.G. Payne, 
Sandoz Ltd., Basel, Switzerland; synthetic IL-8 was a gift from Dr. I. 
Clark-Lewis, Biomedical Research Center and Department of Bio- 
chemistry, University of British Columbia, Vancouver, Canada. Bovine 
serum albumin, fMLP, and lysophosphatidylcholine were purchased 
from Sigma, St. Louis, MO, USA; formaldehyde was from Merck AG, 
Darmstadt, Germany; EDTA was from Fluka AG, Buchs, Switzerland; 
and rhodamine phalloidin was from Molecular Probes Inc., Junction 
City, OR, USA; all other chemicals were obtained as described [12]. 
Concentrated stock solutions were prepared as follows: fMLP and 
HWT (each 10 mM) in dimethyl sulfoxide; C5a (10/IM) in 0.9% (w/v) 
NaCI; and IL-8 (260/tM) in PBS (137 mM NaC1, 2.7 mM KC1, 8.1 mM 
Na2HPO4, 1.5 mM KH2PO4, 0.9 mM CaCI 2, 0.5 mM MgCI2, pH 7.4). 
Stock solutions were further diluted with test buffer (130 mM NaCI, 
5 mM NaHCO3, 4.6 mM KCI, 5 mM glucose, 0.05 mM CaCI2, 20 mM 
EIEPES, pH 7.4), except for IL-8 and C5a, diluted with test buffer 
containing 0.25% (w/v) bovine serum albumin, and injected as 3/A 
pulses into 3 ml of stirred cell suspension i  the sample cuvette of the 
measuring apparatus (below). Neither stirring nor the presence of di- 
methyl sulfoxide in the test medium (final concentration 0.15% v/v, or 
less) affected any of the parameters tested. 
2.2. Cell preparation 
Neutrophils were isolated from buffy coats of single donors as previ- 
ously described [12], suspended in test buffer, and kept at 4 8°C. Aliq- 
uots of this suspension were diluted to a final concentration c = 8 x 10 ~ 
cells/ml (determined in a Sysmex CC-130 microcell counter; TOA Med- 
ical Electronics Co., Kobe, Japan) and warmed to 37°C (or to 25°C for 
experiments carried out at this temperature) for measurement. 
2.3. Shape change measurements 
Light transmission and relative 90 ° scattering were simultaneously 
recorded in an optical multichannel analyzer [13] in ratio mode IlL, 
where I = I~ is the transmitted, 1 = L the 90 ° scattered, and I0 the 
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incident intensity, to compensate for possible fluctuations in source 
intensity. We used a single frequency HeNe laser in combination with 
a 10 x beam expander to provide a stable, highly collimated light 
source; an in-line optical stop prevented strongly forward-scattered 
light appearing outside the dimensions of the exciting beam from reach- 
ing the transmission detector (necessary conditions for quantitative 
extinction measurements on scattering samples [14,15]). Approximately 
300,000 cells were under continuous observation at any given time. 
Transmission data were converted to extinction E=-log(IJ l0 = e~cl 
(BeeFs law), where e~ is the total (decadic) scattering extinction coeffi- 
cient (0.4343 x the particle scattering cross-section, a sensitve measure 
of cell size and/or shape [15,16]) and /-- 1 cm is the path length. The 
turbidity is the extinction per unit path length Eli = e~c (in decadic 
units). 
Oscillations were induced in resting neutrophils as a two-step roc- 
ess. A first or 'oscillation-enabling' dose of either HWT or chemotactic 
peptide was added to the suspension; this addition did not result in the 
production of oscillations (in the case of chemotactic peptide, there was 
a single decrease and recovery in the light scattering signal). Three 
minutes later, a second or 'oscillation-provoking' stimulus was added. 
A train of oscillations ensued after the second and subsequent agonist 
additions. Oscillation frequencies were determined by power spectral 
density analysis after subtracting the mean DC component and the 
non-oscillating transient, as approximated by a smooth polynomial fit 
through the middle of the oscillating portion of the transient. A single 
narrow peak characteristic of a pure sinusoidal response was found in 
almost all instances. Data are expressed as means -+ S.D. 
2.4. Quantflication of F-aetin content 
Total F-actin was determined using a variation of the method of 
Howard and Oresajo [4]. Neutrophils (106 cells/ml) were prewarmed to 
37°C, allowed to react with increasing doses of fMLP for 3 min, and 
fixed for 15 min at 37°C with 3.7% (w/v) formaldehyde (supplemented 
with 2 mM EDTA to prevent cellular aggregation). The cells were then 
permeabilized with 67 pg lysophosphatidylcholine/ml and simultane- 
ously stained with rhodamine phalloidin (0.33,uM) for 15 min at room 
temperature. Five thousand cells per sample were analyzed in a Coulter 
Epics Profile 11 flow cytometer (Coulter Corporation, Hialeah, FL. 
USA). 
3. Results and discussion 
3.1. Oscillations elicited by repeated stimulation of  untreated 
neutrophils 
In this study we examined whether shape oscillations occur 
in untreated neutrophils t imulated by peptide chemoattrac- 
tants encountered under natural  conditions. Suspensions of 
resting neutrophils exposed to a single pulse of IL-8 (0.003 10 
nM), fMLP (0.3 100 nM), or C5a (0.001-10 nM) responded 
with parallel, transient decreases in extinction and 90 ° scatter- 
ing as previously described [5-7] (Fig. 1, left panel). A second 
and third st imulation of the same cells by the same stimulus led 
to scattering changes characterized by the appearance of a 
damped train of prominent,  regular oscillations having a period 
Table 1 
Oscillation frequencies in light scattering responses of neutrophils pro- 
treated with HWT and stimulated with a single agonist pulse 
Stimulus Oscillation frequency in Hz 
Extinction 90 ° scattering 
fMLP, l0 nM 0.122 + 0.012 (45) 0.124 + 0.009 (63) 
IL-8, 25 nM 0.118_+0.013(10) 0.117_+0.014(13) 
C5a. 10 nM 0.122 _+ 0.010 (3) 0.119 + 0.(/05 (4) 
Power spectral density estimates. Cells were preincubated with I yM 
HWT for 10 min at 37°C. Mean values _+ S.D.; parentheses nclose 
the number of independent experiments. Similar results were obtained 
using phorbo112-myristate 13-acetate (2.5 3.5 nM) instead ofHWT fl~r 
pretreatment. 
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Fig. I. Shape oscillations in untreated neutrophils revealed by repetitive 
stimulation. Relative changes in 90 ° scattering (top) and extinction 
(bottom) of cells stimulated at 3 min intervals (arrows); the stimulus 
sequence was 1 nM IL-8, 10 nM IL-8, and 10 nM fMLE Similar results 
were obtained using fMLP or C5a as the first stimulus. 
of 8 10 s (Fig. 1, middle and right panels). Because these oscil- 
lations were not evident after the first agonist addition, it seems 
likely that the first agonist- induced response establishes the 
biochemical condit ions that favor oscillations in the second and 
third stimulation. 
To determine if the oscillation frequency depends on the 
concentrat ion of the preactivating agonist, we enabled oscilla- 
tions with varying chemoattractant  doses and held the agonist 
concentrat ion of the second addit ion constant. The frequency 
of the oscillation provoked by the second agonist addition 
increased in a dose-dependent fashion as the concentrat ion of 
the enabling stimulus was increased (Fig. 2). IL-8 generated 
higher oscillation frequencies, with a maximum of 0.16 Hz 
compared to 0.14 for fMLE  An oscil lation-enabling effect of 
very small first-stimulus concentrat ions is evident from the data 
of Fig. 2. As little as 3 pM IL-8 (or 1 pM C5a, data not shown) 
led to second-stimulus o cillations of small constant frequency 
(0.098 + 0.002 Hz, n -- 3). The oscillations were strikingly simi- 
lar to those observed using cells preincubated with HWT [7,9] 
(Fig. 3, left panel) or stimulated with lipid agonists [8]. In each 
case, the oscillations appear to be superimposed on an underly- 
ing average transient. This suggests that neutrophil  shape 
change is composed of a high amplitude, low frequency compo- 
nent and a high frequency oscillating component.  Such a behav- 
ior is predicted by the model proposed by Wymann et al. [9]. 
Since pretreatment with either peptide agonist or HWT permits 
induction of oscillations, it is likely that both enabeling treat- 
ments operate through a common pathway. As HWT [17] and 
C5a [18] are known to inhibit phosphatidyl inositol  3-kinase, 
this enzyme could be involved in regulation of the oscillations. 
3.2. Oscillations in neutrophils pretreated with 
(17-hydroxy)wortmannin (HWT)  
Oscillations of similar frequency and amplitude were elicited 
by single pulses of fMLP, IL-8, and C5a in cells pretreated with 
HWT (Table 1) or wortmannin (data not shown). Since the 
frequency seemed to be independent of the type of oscillation- 
provoking stimulus, we averaged the frequencies for all stimuli. 
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Fig. 2. Increase in 90 ° scattering response frequencies as a function of 
first-stimulus (enabling) agonist concentration. Untreated neutrophils 
were stimulated with variable amounts of IL-8 (circles) or fMLP 
(squares), followed after 3 min with a pulse of constant agonist concen- 
tration (10 nM in each case). Mean values + S.D. of 2-19 independent 
neutrophil preparations are shown. 
The mean frequency was 0.120 + 0.011 Hz (n = 239; Table 2, 
line 1), corresponding to a mean period of 8.4 s. This frequency 
was independent of the agonist concentration (fMLP, 1 30 riM; 
and lL-8, 0.3 25 nM), which supports the concept that the 
oscillation frequency depends upon the oscillation-enabling 
event rather than the nature or concentration of the stimulus 
which provokes the oscillatory transient. To see if the enabling 
effects of peptide agonist and HWT were additive, we repeat- 
edly provoked shape oscillations in HWT-pretreated cells (Fig. 
3, middle and right panels). Each subsequent addition of pep- 
tide agonist resulted in a continued increase of the oscillation 
frequency (Table 2). As these cells had been pretreated with 
1 HM HWT, a dose which is known to completely block 
phosphatidylinositol 3-kinase [17], factors other than or in ad- 
dition to phosphatidylinositol 3-kinase must be involved in the 
regulation of the oscillations. 
To explore whether the mechanism controlling oscillations 
in actin polymerization is similar to that which regulates oscil- 
lations in the respiratory burst [11], we determined the activa- 
tion energy of the actin polymerization-coupled scattering 
changes. Lower frequency oscillations were found at 25°C than 
at 37°C and resulted in an Arrhenius activation energy of 69 
(extinction) and 65 kJ/mol (90 ° scattering) for shape oscilla- 
tions. This compares favorably with the value of 61 kJ/mol 
Table 2 
Increase in light scattering oscillation frequency of repeatedly stimu- 
lated HWT-pretreated neutrophils 
Stimulus Oscillation frequency in Hz and significance P for: 
Extinction P 90 ° scattering P 
1st 0.119+0.012(91) - 0.121_+0.010(148) 
2nd 0.130_+0.013 (98) <0.001 0.134_+0.012(122) <0.001 
3rd 0.142 _+ 0.016 (15) 0.0016 0.145 + 0.013 (22) <0.001 
Power spectral density estimates. Combined results using fMLP, IL-8 
and C5a (each 1 30 nM). The cells were preincubated for 10 min with 
1/JM HWT at 37°C and stimulated with an agonist at 3 rain intervals. 
Mean values + S.D.; parentheses nclose the number of independent 
experiments. P is the probability that the oscillation frequency is the 
same as that obtained in the previous timulation (Student's t-test). 
reported previously for respiratory burst oscillations [11]. Our 
results are consistent with other reports suggesting that regula- 
tion of the neutrophil respiratory burst is linked to regulation 
of the cytoskeleton [19]; however, the exact mechanism of the 
oscillations at the molecular level remains to be determined. 
Since the oscillations have such a clearly sinusoidal wave- 
form, it seems likely that these oscillations represent a dynamic 
equilibrium between a small number of molecular species. Can- 
didate species involved in this equilibrium could be globular 
and F-actin, or the labile and stabile pools of F-actin, thought 
to drive lamellipod protrusion [20,21]. Proteins which modulate 
actin polymerization and cross-linking offer many possibilities 
for frequency and amplitude regulation of this dynamic equilib- 
rium. 
3.3. The role o f  F-actin 
Because the oscillations reflect periodic transitions between 
the pools of globular and filamentous actin [9], the size of the 
total F-actin pool at the time the oscillation-provoking a onist 
is added could determine the frequency. We measured the F- 
actin 3 min after addition of the first peptide agonist, i.e. at a 
time just before the second stimulation. Although increasing 
fMLP concentrations led to increasing total F-actin content 
3 min after stimulation, total F-actin was not linearly correlated 
with the oscillation frequency. Furthermore, IL-8 produced no 
changes in total F-actin sampled at the same time point. Thus, 
total F-actin at the time the second stimulus is added does not 
appear to influence the frequency of the resulting oscillations. 
The mechanical oscillations due to actin polymerization and 
detected by light scattering are likely to represent a process that 
is critical to amoeboid movement. During their random walk 
on surfaces, neutrophils move in approximately straight paths 
separated, at certain time intervals, by discrete changes in direc- 
tion. At 37°C, a mean transit time of slightly under a minute 
was determined as the characteristic time of the 'internal clock' 
between successive directional changes [22]. This time corre- 
sponds nicely to the duration of the train of shape oscillations 
we see in suspension. Interestingly, our recent studies on mi- 
grating neutrophils clearly detect mechanical oscillations with 
A 
._c 97 
93 ' =~~ 
c~ 89  
~ 85  
c 99  .o 
0 
.~ 97 
x 
w 95 ~ , . J t 
0 50  180  230 360 410 
Time (s) 
Fig. 3. Shape oscillations induced by repeated stimulation of HWT- 
pretreated neutrophils. Relative changes in 90 ° scattering (top) and 
extinction (bottom) of cells pretreated with 1/~M H WT (10 min) and 
stimulated at 3 rain intervals with 10 nM fMLP (arrows). Similar esults 
were obtained using IE-8 or C5a as the first stimulus. 
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a period of 8 l0 s [23], corresponding closely to those detected 
in suspension. Taken as a whole, these data suggest hat the 
peptide-induced oscillations een in cell suspensions are likely 
to be relevant o periodic shape alterations detected in crawling 
neutrophils. Furthermore, our finding that the oscillation-ena- 
bling event determines the frequency characteristics of subse- 
quent oscillations could provide a plausible explanation for the 
neutrophil memory which results in highly correlated [23], per- 
sistent [24] motion. 
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